U.S. market Closed. Opens in 1 day 23 hours 13 minutes

SGMT | Sagimet Biosciences Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.00MN/AN/AN/AN/A
Cost of RevenueN/A130.00K134.00K124.00K88.00K
Gross Profit2.00M-130.00K-134.00K-124.00K-88.00K
Operating Expenses32.74M31.05M23.72M11.40M14.25M
Selling, General & Admin12.96M6.14M4.38M3.22M5.86M
Research & Development19.78M24.92M19.34M8.18M8.39M
Other Operating ExpensesN/A3.00K-749.00KN/A-73.00K
Operating Income-30.74M-31.05M-23.72M-11.40M-14.25M
Other Expenses / Income2.86M556.00K-723.00K30.00K-9.00K
Before Tax Income-27.88M-30.50M-24.44M-11.37M-14.26M
Income Tax ExpensesN/A-31.61M-23.75M-176.30K-9.00K
Net Income-27.88M-30.50M-24.44M-11.37M-14.26M
Interest ExpensesN/AN/AN/AN/A64.00K
Basic Shares Outstanding10.46M22.17M22.17M22.17M22.17M
Diluted Shares Outstanding10.46M22.17M22.17M22.17M22.17M
EBITDA-30.74M-30.37M-24.31M-11.25M-14.11M
EBITDA Margin-1,537.00%0.00%0.00%0.00%0.00%
EBIT-27.88M-62.11M-48.19M-11.55M-14.21M
EBIT Margin-1,393.80%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙